NEXT GENERATION MEDICINES – BEYOND SMALL MOLECULEs AND MONOCLONAL ANTIBODIES

A FUNDAMENTALLY NEW APPROACH TO RAPIDLY DEVELOP NOVEL AND MORE EFFECTIVE THERAPEUTICS

As pioneers creating highly specific bio-functional molecules, Anven is focused on developing unique therapeutics that are orally bioavailable, penetrate cell membranes, transit the blood brain barrier, and target both intra- and extra-cellular targets. The Anven platform offers systematic identification of extraordinarily robust compounds enabling new, more effective therapeutics for neurodegenerative, autoimmune, cancer, and infectious diseases.